Keyphrases
Disease Progression
100%
Patients with Heart Failure
100%
Disease Pathogenesis
100%
Plasma Proteomics
100%
Novel Therapeutic Targets
100%
Proteomic Approach
100%
Disease Potential
100%
Poor Outcome
25%
Clinical Outcomes
12%
Network Analysis
12%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
12%
Metabolic Processes
12%
Proline
12%
Electrospray Ionization Mass Spectrometry
12%
Glutathione
12%
Arginine
12%
Expression Change
12%
Targets for Therapy
12%
Protein-protein Interaction Network
12%
Glutathione Metabolism
12%
Differentially Expressed Proteins
12%
Two-dimensional Liquid Chromatography
12%
2D-LC
12%
Arginine Metabolism
12%
Gene Ontology Enrichment Analysis
12%
Rehospitalization
12%
Pyruvate Metabolism
12%
HDMSE
12%
Proline Metabolism
12%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
100%
Proteomics
100%
Metabolic Pathway
66%
Proteome
66%
Proline
66%
Arginine
66%
Tandem Mass Spectrometry
33%
Tandem Mass Spectrometry
33%
Glutathione Metabolism
33%
Gene Ontology
33%
Electrospray Ionization
33%
Glutathione
33%
Protein-Protein Interaction Networks
33%
Medicine and Dentistry
Disease Exacerbation
100%
Congestive Heart Failure
100%
Proteomics
100%
Arginine
25%
Proline
25%
Pyruvic Acid
25%
Proteome
25%
Glutathione
12%
Glutathione Metabolism
12%
Electrospray Ionization
12%
Tandem Mass Spectrometry
12%
Tandem Mass Spectrometry
12%
Two Dimensional Liquid Chromatography
12%
Protein-Protein Interaction Networks
12%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Exacerbation
100%
Congestive Heart Failure
100%
Proline
25%
Glutathione
25%
Arginine
25%
Pyruvic Acid
25%
Proteome
25%